KDR and gastric cancer: However, there were several other non‐gastric cancer, such as colorectal cancer, ovarian cancer, primary peritoneal, or fallopian tube cancer, neuroendocrine tumor, showing tumor response to anti‐VEGFR2 antibodies.4, 5, 6